Enhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli gene

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 5, 2012, Pages 1085-1093

  Qadri, Syed M ^a   Mahmud, Hasan ^a   Lang, Elisabeth ^a   Gu, Shuchen ^a   Bobbala, Diwakar ^a   Zelenak, Christine ^a   Jilani, Kashif ^a   Siegfried, Alexandra ^a   Föller, Michael ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

APC; Calcium; Cell membrane scrambling; Cell volume; Eryptosis; Phosphatidylserine

Indexed keywords

AMILORIDE; APC PROTEIN; CALCIUM; CALCIUM IONOPHORE; IONOMYCIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE; SODIUM CHANNEL BLOCKING AGENT;

ANIMAL; APOPTOSIS; ARTICLE; DRUG EFFECT; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; FEMALE; GENETICS; MALE; METABOLISM; MOUSE; MUTATION; PHYSIOLOGY; SPLEEN; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; AMILORIDE; ANIMALS; ANNEXIN A5; APOPTOSIS; CALCIUM; CALCIUM IONOPHORES; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FEMALE; GENES, APC; IONOMYCIN; MALE; MICE; MUTATION; PHOSPHATIDYLSERINES; SODIUM CHANNEL BLOCKERS; SPLEEN;

ANIMALIA; MUS;

EID: 84860348582     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01387.x     Document Type: Article

References (68)

1. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta. 2003; 1653: 1-24.
2. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 1997; 275: 1784-7.
3. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997; 275: 1787-90.
4. Polakis P. Wnt signaling and cancer. Genes Dev. 2000; 14: 1837-51.
5. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998; 281: 1509-12.
6. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999; 398: 422-6.
7. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996; 87: 159-70.
8. Smith KJ, Johnson KA, Bryan TM, et al. The APC gene product in normal and tumour cells. Proc Natl Acad Sci U S A. 1993; 90: 2846-50.
9. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 1990; 247: 322-4.
10. Rotte A, Bhandaru M, Foller M, et al. APC sensitive gastric acid secretion. Cell Physiol Biochem. 2009; 23: 133-42.
11. Bhandaru M, Kempe DS, Rotte A, et al. Hyperaldosteronism, hypervolemia, and increased blood pressure in mice expressing defective APC. Am J Physiol Regul Integr Comp Physiol. 2009; 297: R571-75.
12. Ousingsawat J, Spitzner M, Schreiber R, et al. Upregulation of colonic ion channels in APC (Min/+) mice. Pflugers Arch. 2008; 456: 847-55.
13. Lang F, Gulbins E, Lerche H, et al. Eryptosis, a window to systemic disease. Cell Physiol Biochem. 2008; 22: 373-80.
14. Foller M, Mahmud H, Gu S, et al. Modulation of suicidal erythrocyte cation channels by an AMPA antagonist. J Cell Mol Med. 2009; 13: 3680-6.
15. Bernhardt I, Weiss E, Robinson HC, et al. Differential effect of HOE642 on two separate monovalent cation transporters in the human red cell membrane. Cell Physiol Biochem. 2007; 20: 601-6.
16. Duranton C, Huber SM, Lang F. Oxidation induces a Cl(-)-dependent cation conductance in human red blood cells. J Physiol. 2002; 539: 847-55.
17. Duranton C, Huber S, Tanneur V, et al. Electrophysiological properties of the Plasmodium Falciparum-induced cation conductance of human erythrocytes. Cell Physiol Biochem. 2003; 13: 189-98.
18. Huber SM, Gamper N, Lang F. Chloride conductance and volume-regulatory nonselective cation conductance in human red blood cell ghosts. Pflugers Arch. 2001; 441: 551-8.
19. Kaestner L, Christophersen P, Bernhardt I, et al. The non-selective voltage-activated cation channel in the human red blood cell membrane: reconciliation between two conflicting reports and further characterisation. Bioelectrochemistry. 2000; 52: 117-25.
20. Kaestner L, Bernhardt I. Ion channels in the human red blood cell membrane: their further investigation and physiological relevance. Bioelectrochemistry. 2002; 55: 71-4.
21. Lang KS, Duranton C, Poehlmann H, et al. Cation channels trigger apoptotic death of erythrocytes. Cell Death and Differentiation. 2003; 10: 249-56.
22. Bookchin RM, Ortiz OE, Lew VL. Activation of calcium-dependent potassium channels in deoxygenated sickled red cells. Prog Clin Biol Res. 1987; 240: 193-200.
23. Brugnara C, de Franceschi L, Alper SL. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest. 1993; 92: 520-6.
24. Lang PA, Kaiser S, Myssina S, et al. Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol. 2003; 285: C1553-60.
25. Berg CP, Engels IH, Rothbart A, et al. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ. 2001; 8: 1197-206.
26. Brand VB, Sandu CD, Duranton C, et al. Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte. Cell Physiol Biochem. 2003; 13: 347-56.
27. Bratosin D, Estaquier J, Petit F, et al. Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ. 2001; 8: 1143-56.
28. Daugas E, Cande C, Kroemer G. Erythrocytes: death of a mummy. Cell Death Differ. 2001; 8: 1131-3.
29. Lang KS, Myssina S, Brand V, et al. Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ. 2004; 11: 231-43.
30. Foller M, Feil S, Ghoreschi K, et al. Anaemia and splenomegaly in cGKI-deficient mice. Proc Natl Acad Sci U S A. 2008; 105: 6771-6.
31. Foller M, Sopjani M, Koka S, et al. Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J. 2009; 23: 1072-80.
32. Kempe DS, Lang PA, Duranton C, et al. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J. 2006; 20: 368-70.
33. Lang PA, Kasinathan RS, Brand VB, et al. Accelerated clearance of Plasmodium-infected erythrocytes in sickle cell trait and annexin-A7 deficiency. Cell Physiol Biochem. 2009; 24: 415-28.
34. Klarl BA, Lang PA, Kempe DS, et al. Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. Am J Physiol Cell Physiol. 2006; 290: C244-53.
35. Fadok VA, Bratton DL, Rose DM, et al. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature. 2000; 405: 85-90.
36. Boas FE, Forman L, Beutler E. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anaemia. Proc Natl Acad Sci U S A. 1998; 95: 3077-81.
37. Colloca G, Venturino A, Vitucci P, et al. Management of anaemia in prostate cancer. Cancer Invest. 2010; 28: 280-8.
38. Spivak JL, Gascon P, Ludwig H. Anaemia management in oncology and hematology. Oncologist. 2009; 14: 43-56.
39. Half E, Bercovich D, Rozen P. Familial adenomatous polyposis. Orphanet J Rare Dis. 2009; 4: 22.
40. Bhavsar SK, Bobbala D, Xuan NT, et al. Stimulation of suicidal erythrocyte death by alpha-lipoic acid. Cell Physiol Biochem. 2010; 26: 859-68.
41. Bhavsar SK, Eberhard M, Bobbala D, et al. Monensin induced suicidal erythrocyte death. Cell Physiol Biochem. 2010; 25: 745-52.
42. Eberhard M, Ferlinz K, Alizzi K, et al. FTY720-induced suicidal erythrocyte death. Cell Physiol Biochem. 2010; 26: 761-6.
43. Lang F, Gulbins E, Lang PA, et al. Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem. 2010; 26: 21-8.
44. Braun M, Foller M, Gulbins E, et al. Eryptosis triggered by bismuth. Biometals. 2009; 22: 453-60.
45. Mahmud H, Mauro D, Qadri SM, et al. Triggering of suicidal erythrocyte death by amphotericin B. Cell Physiol Biochem. 2009; 24: 263-70.
46. Mahmud H, Mauro D, Foller M, et al. Inhibitory effect of thymol on suicidal erythrocyte death. Cell Physiol Biochem. 2009; 24: 407-14.
47. Mahmud H, Foller M, Lang F. Arsenic-induced suicidal erythrocyte death. Arch Toxicol. 2009; 83: 107-13.
48. Birka C, Lang PA, Kempe DS, et al. Enhanced susceptibility to erythrocyte "apoptosis" following phosphate depletion. Pflugers Arch. 2004; 448: 471-7.
49. Lang PA, Beringer O, Nicolay JP, et al. Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med. 2006; 84: 378-88.
50. Kempe DS, Akel A, Lang PA, et al. Suicidal erythrocyte death in sepsis. J Mol Med. 2007; 85: 269-77.
51. Bobbala D, Alesutan I, Foller M, et al. Effect of anandamide in Plasmodium Berghei-infected mice. Cell Physiol Biochem. 2010; 26: 355-62.
52. Foller M, Bobbala D, Koka S, et al. Suicide for survival-death of infected erythrocytes as a host mechanism to survive malaria. Cell Physiol Biochem. 2009; 24: 133-40.
53. Siraskar B, Ballal A, Bobbala D, et al. Effect of amphotericin B on parasitemia and survival of plasmodium berghei-infected mice. Cell Physiol Biochem. 2010; 26: 347-54.
54. Koka S, Bobbala D, Lang C, et al. Influence of paclitaxel on parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem. 2009; 23: 191-8.
55. Lang PA, Schenck M, Nicolay JP, et al. Liver cell death and anaemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med. 2007; 13: 164-70.
56. Andrews DA, Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol. 1999; 6: 76-82.
57. Closse C, Dachary-Prigent J, Boisseau MR. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol. 1999; 107: 300-2.
58. Gallagher PG, Chang SH, Rettig MP, et al. Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood. 2003; 101: 4625-7.
59. Pandolfi A, Di Pietro N, Sirolli V, et al. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol. 2007; 213: 699-709.
60. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood. 1996; 88: 1873-80.
61. Chung SM, Bae ON, Lim KM, et al. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol. 2007; 27: 414-21.
62. Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci. 2005; 62: 971-88.
63. 2 increases?J Cardiometab Syndr. 2008; 3: 30-4.
64. st World Congress on the Insulin Resistance Syndrome. Diabetes Care. 2004; 27: 824-30.
65. Hopkins TG, Salem V, El Gayar H, et al. Familial adenomatous polyposis and hypertension. Lancet. 2010; 375: 1752.
66. Kriebardis AG, Antonelou MH, Stamoulis KE, et al. Progressive oxidation of cytoskeletal proteins and accumulation of denatured hemoglobin in stored red cells. J Cell Mol Med. 2007; 11: 148-55.
67. JG Fox, MT Davisson, FW Quimby, et al. The Mouse in Biomedical Research. Academic Press: New York, 2006.
68. MA Suckow, P Danneman, C Brayton. The laboratory mouse. Boca Raton: CRC Press; 2001.